Red & Near-Infrared Light for Pain and Physical Recovery

Pain and physical recovery is the part of the light-therapy literature with the most substance behind it. That does not make it simple. The findings are condition-specific, protocol-specific, and consistently accompanied by caveats about evidence quality — all of which get stripped out by the time a claim reaches a product page.

The 2025 umbrella review of photobiomodulation pooled 15 meta-analyses covering 204 randomized controlled trials and more than 9,000 participants across 35 outcomes. Twelve outcomes showed statistically significant effects. Certainty ranged from very low to moderate, and nothing reached high certainty — with moderate-certainty findings reported for outcomes including pain in burning mouth syndrome, knee osteoarthritis disability, fibromyalgia-related fatigue and hair density.

Read that carefully and a rule emerges: the effect sizes are real but modest, and the credible use case is adjunct support inside a broader rehabilitation plan rather than standalone therapy.

The most instructive dataset comes from low-level red and near-infrared photobiomodulation for pain and function in tendinopathy — 17 randomized controlled trials with 835 participants. Light combined with exercise outperformed sham plus exercise on pain and function, with variable evidence quality across studies.

The design detail is the lesson. Both groups exercised. The question was never whether light replaces loading; it was whether light adds anything on top of loading. That is the right way to frame every recovery claim in this field.

Inflammation is not one process. Asking whether light reduces inflammation is like asking whether exercise improves health — true enough to be useless. Reviews of mitochondrial redox signalling in photobiomodulation describe plausible effects on oxidative signalling and inflammatory mediators, which is a reason to run trials in named conditions rather than a licence to make blanket claims.

The leading mechanistic explanation centers on cytochrome c oxidase, a mitochondrial enzyme that absorbs red and near-infrared wavelengths and, in response, appears to modestly increase ATP production and modulate reactive oxygen species signalling. That is a plausible biological story, but plausibility is not proof of clinical benefit at any given dose in any given condition — which is exactly why the condition-by-condition trial data above matters more than the mechanism alone.

Dose-response in photobiomodulation is described in the literature as biphasic: too little energy produces no measurable effect, and too much can blunt or reverse the benefit seen at moderate doses. That single fact explains much of the inconsistency across commercial devices and protocols, since wavelength, irradiance, distance from skin, and session duration all shift the effective dose delivered to tissue.

At Sanctuary Tulum, light exposure is treated as one input among several rather than a headline therapy, layered alongside hyperbaric oxygen therapy, infrared sauna sessions, and therapeutic bodywork under the broader Pouyan Method™ framework. For guests recovering from injury or surgery, movement-based rehabilitation and physician oversight remain the foundation, with light therapy positioned as a supportive adjunct rather than a stand-alone treatment.

Guests interested in the broader physiological rationale behind light exposure, circadian regulation and mitochondrial support can review the full Light System™ research guide, or read about complementary recovery modalities such as cold plunge therapy and NAD+ IV therapy. None of these are presented as a substitute for a physician's diagnosis and treatment plan.

Get a diagnosis before treating pain with anything. Keep light as an adjunct to loading, mobility work and professional rehabilitation. Expect modest, cumulative change rather than a dramatic response, and note that dose in PBM is biphasic — more is not better. Anyone with photosensitivity, on a photosensitizing medication, pregnant, or with an active malignancy should consult a physician before using any light device.

The recovery literature points consistently in one direction: light is an addition to loading, not an alternative to it. In the tendinopathy trials both groups exercised, and the osteoarthritis reviews cautioned explicitly against isolated use. A protocol built on that finding starts with an accurate diagnosis, then progressive loading, mobility work and adequate protein and sleep, and only then adds an adjunct.

Dose deserves the same discipline. Because photobiomodulation is biphasic, extending sessions or increasing intensity beyond manufacturer guidance is as likely to reduce any effect as to increase it. Consistency across weeks matters more than intensity within a session, and the change to expect is modest and cumulative rather than dramatic — anything described as immediate and complete relief is describing marketing, not the evidence.

Tracking makes the difference between guessing and knowing. Record one or two outcomes that matter — pain on a specific movement, range of motion, tolerated load, or a validated function score — before starting, then reassess after four to six weeks. If nothing has moved while the fundamentals were in place, the adjunct is not contributing for that condition. Persistent, worsening or unexplained pain should always be assessed by a physician first.

Related reading: red light therapy, cold plunge therapy, and the full Light System™ research guide.

Educational information only. Not medical advice, and not an offer of The Light System™ as a service at Sanctuary Tulum.